Literature DB >> 9306875

Synovial fluid concentrations of the C-propeptide of type II collagen correlate with body mass index in primary knee osteoarthritis.

T Kobayashi1, Y Yoshihara, A Samura, H Yamada, M Shinmei, H Roos, L S Lohmander.   

Abstract

OBJECTIVE: To explore in a cross sectional study in patients with primary knee osteoarthritis (OA) the relations between body mass index (BMI), disease stage, and the concentrations of a putative joint fluid marker of type II collagen synthesis, procollagen II C-propeptide. PATIENTS AND METHODS: The study included 142 patients with knee OA (median age 68, median BMI 24.1). OA was staged radiologically. The concentrations in synovial fluid of procollagen II C-propeptide were measured by a sandwich enzyme immunoassay.
RESULTS: Joint fluid concentrations of procollagen II C-propeptide were increased in knees with OA (median 3.7 ng/ml), compared with published reference values for knees in healthy adult volunteers (median 1.3 ng/ml). The concentrations of procollagen II C-propeptide were independently related to both OA stage and BMI (r = 0.343, p < 0.0001 and r, = 0.253, p = 0.002, respectively).
CONCLUSIONS: Joint fluid concentrations of this putative marker of collagen II synthesis are high in early and mid-stage OA, but decrease in end stage disease. In addition and for the first time it was shown that the concentrations in synovial fluid of procollagen II C-propeptide increase with increasing BMI in primary knee OA. The increased joint fluid values of this marker in patients with primary knee OA and a high BMI, may reflect increased rates of collagen synthesis in their joint cartilage and could relate to the previously shown increased risk for disease progression in such patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9306875      PMCID: PMC1752424          DOI: 10.1136/ard.56.8.500

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  8 in total

1.  Procollagen II C propeptide level in the synovial fluid as a predictor of radiographic progression in early knee osteoarthritis.

Authors:  S Sugiyama; M Itokazu; Y Suzuki; K Shimizu
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

2.  Concentrations of CTX I, CTX II, DPD, and PYD in the urine as a biomarker for the diagnosis of temporomandibular joint osteoarthritis: A preliminary study.

Authors:  Soo-Min Ok; Seung-Min Lee; Hae Ryoun Park; Sung-Hee Jeong; Ching-Chang Ko; Yong-Il Kim
Journal:  Cranio       Date:  2017-08-07       Impact factor: 2.020

3.  Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis.

Authors:  V B Kraus; B Burnett; J Coindreau; S Cottrell; D Eyre; M Gendreau; J Gardiner; P Garnero; J Hardin; Y Henrotin; D Heinegård; A Ko; L S Lohmander; G Matthews; J Menetski; R Moskowitz; S Persiani; A R Poole; J-C Rousseau; M Todman
Journal:  Osteoarthritis Cartilage       Date:  2011-03-23       Impact factor: 6.576

4.  Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study.

Authors:  T Conrozier; T Saxne; C S Fan; P Mathieu; A M Tron; D Heinegård; E Vignon
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

5.  Biochemical Markers for the Early Identification of Osteoarthritis: Systematic Review and Meta-Analysis.

Authors:  Guomin Ren; Roman J Krawetz
Journal:  Mol Diagn Ther       Date:  2018-12       Impact factor: 4.074

6.  Serum levels of PIICP, PIIANP, and PIIBNP are decreased in patients with an endemic osteochondropathy, Kashin-Beck disease.

Authors:  Wei Lian; Hui Liu; Li Yan Sun; Yun Qi Liu; Si Lu Cui; Yue Wang; Quan Quan Song; Qing Deng; Shao Ping Wang; Yan Hong Cao; Xue Ying Zhang; Yuan Yuan Jiang; Hong Yan Lv; Li Bin Duan; Jun Yu
Journal:  J Orthop Surg Res       Date:  2018-05-29       Impact factor: 2.359

7.  A Novel High Sensitivity Type II Collagen Blood-Based Biomarker, PRO-C2, for Assessment of Cartilage Formation.

Authors:  Yunyun Luo; Yi He; Ditte Reker; Natasja Stæhr Gudmann; Kim Henriksen; Ole Simonsen; Christoph Ladel; Martin Michaelis; Ali Mobasheri; Morten Karsdal; Anne-Christine Bay-Jensen
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

8.  Collagen biomarkers for arthritis applications.

Authors:  James D Birmingham; Vladimir Vilim; Virginia B Kraus
Journal:  Biomark Insights       Date:  2007-02-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.